Amplified expression of tumor necrosis factor receptor in cells transfected with Epstein-Barr virus shuttle vector cDNA libraries.
As an approach to isolate the cell-surface receptor for tumor necrosis factor (TNF), we have developed transfectants of human B-lymphoblastoid cells (UC cells) that overexpress the TNF receptor. These transfectants were isolated from UC cells transfected with cDNA libraries of HeLa or NG108 cells constructed in the mammalian expression vector EBO-pcD. This vector contains the Epstein-Barr virus origin of replication (ori-P) plus the EBNA-1 gene conferring replication function to ori-P and, therefore, the ability to replicate autonomously within the transfected cell (Margolskee, R.F., Kavathas, P., and Berg, P. (1988) Mol. Cell. Biol. 8, 2837-2947). Cells overexpressing the TNF receptor were identified and separated by the binding of fluoresceinated TNF and flow cytometric selection. Scatchard analysis of 125I-TNF binding data revealed a single class of high affinity receptors with a dissociation constant (Kd) of 0.2 to 2 nM and a receptor density of about 150,000 per cell, an increase of approximately 150-fold over UC cells. Cross-linking of receptor-ligand with bis-sulfosuccinimidyl suberate followed by polyacrylamide gel electrophoresis gave estimates of 87 and 104 kDa for the size of the complex. Based on its ability to bind TNF, a 68-kDa receptor protein was identified in cell extracts enriched for the receptor by using immobilized wheat germ agglutinin and TNF affinity chromatography. The difference in the estimated size of the receptor and the receptor-ligand complexes demonstrates that TNF binds to the receptor as a monomer or a dimer. Analysis of cDNA sequences conferring receptor amplification in transfectants revealed that plasmid DNA was present at 30 or more copies per cell, most likely integrated into the genomic DNA or organized into high molecular weight catenanes, and autonomously replicating units could not be recovered. Therefore, while this vector was useful in generating stable receptor-amplified cells, it was not maintained as a recoverable episome.
Heller
R A
RA
Institue of Cancer and Developmental Biology, Syntex Research, Palo Alto, California 94304.
Song
K
K
Villaret
D
D
Margolskee
R
R
Dunne
J
J
Hayakawa
H
H
Ringold
G M
GM
D000818:Animals; D001402:B-Lymphocytes / Q000378:metabolism; D002461:Cell Line, Transformed; D003432:Cross-Linking Reagents; D004247:DNA / Q000235:genetics*; D005434:Flow Cytometry; D005784:Gene Amplification; D015870:Gene Expression; D005822:Genetic Vectors; D005910:Glioma; D006367:HeLa Cells; D004854:Herpesvirus 4, Human / Q000235:genetics*; D006822:Hybrid Cells; D046911:Macromolecular Substances; D051379:Mice; D009447:Neuroblastoma; D010957:Plasmids; D051381:Rats; D011956:Receptors, Cell Surface / Q000235:genetics* / Q000302:isolation & purification; D018124:Receptors, Tumor Necrosis Factor; D015183:Restriction Mapping; D013388:Succinimides; D014162:Transfection; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D003432:Cross-Linking Reagents; D046911:Macromolecular Substances; D011956:Receptors, Cell Surface; D018124:Receptors, Tumor Necrosis Factor; D013388:Succinimides; D014409:Tumor Necrosis Factor-alpha; D004247:DNA; C035760:bis(sulfosuccinimidyl)suberate